Natural Capsules enterprise value

·Pharma & HealthChart ›
MultiplesEnterprise valuePer share
Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025
142——
0.20.20.7
13.113.124.2
114114104
269——
114114103
₹258.92——
349349361
32.8%32.8%28.8%
0.43×——
1.41×——
−354.21×——
−14.92×——
Reference items — trailing FY values
191187169
−0.8−1.617.5
−18.0−18.78.4
—10.926.8
−0.6−0.6−17.9
—−1.9−21.7
—11.544.6
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

NATCAPSUQ₹136.44

Natural Capsules Limited

· Pharma & Health
₹ CrorePeersNECLIFEAAREYDRUGSBALPHARMAALPAKREBSBIOMEDICAMEQMEDICOVINEETLABMcap ₹142 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization——141.7
- Cash, Equiv & ST Investments0.70.20.2
+ Minority Interest24.213.113.1
+ Total Debt103.8114.3114.3
Enterprise Value——268.9
Net Debt (memo)103.1114.1114.1
EV per Share——258.92
Total Capital361.0349.1349.1
Total Debt/Total Capital28.7632.7632.76
Total Debt/EV——0.43
EV/Sales——1.41
EV/EBITDA——-354.21
EV/EBIT——-14.92
Reference Items — Trailing FY Values
Sales169.2187.2190.7
EBITDA17.5-1.6-0.8
EBIT8.4-18.7-18.0
Operating Cash Flow26.810.9—
Free Cash Flow-17.9-0.6-0.6
FCFF (free cash flow to the firm)-21.7-1.9—
Capital Expenditure44.611.5—
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.